Next Article in Journal
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs: Preliminary Results Regarding Efficacy and Safety
Previous Article in Journal
Effects of Dietary Protein Levels, Net Energy Levels, and Essential Amino Acid-to-True Protein Ratios on Broiler Performance
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Lysophospholipid Supplementation in Broiler Breeders’ Diet Benefits Offspring’s Productive Performance, Blood Parameters, and Hepatic β-Oxidation Genes

1
Department of Animal Sciences, College of Agriculture, Isfahan University of Technology, Isfahan 84156-83111, Iran
2
Department of Animal and Poultry Nutrition, Faculty of Animal Science, Gorgan University of Agricultural Sciences and Natural Resources, Shahid Beheshti Ave, Gorgan 49138-15739, Iran
3
Department of Poultry Science, University of Georgia, Athens, GA 30602, USA
*
Author to whom correspondence should be addressed.
Animals 2024, 14(21), 3066; https://doi.org/10.3390/ani14213066
Submission received: 12 August 2024 / Revised: 18 September 2024 / Accepted: 27 September 2024 / Published: 24 October 2024
(This article belongs to the Section Poultry)

Abstract

:

Simple Summary

The growth and vitality of bird embryos during incubation are solely dependent on the nutrients deposited in the eggs. Lysophospholipid, a type of emulsifier, has been included in poultry diets to promote lipid digestion and absorption. This research aimed to explore the potential benefits of adding lysophospholipid to the diet of broiler-type breeders on their offspring. Four test diets were formulated with two energy levels and two levels of lysophospholipid supplementation. The experimental diets were fed to a total of 264 49-week-old breeder hens for periods of 8 and 12 weeks, and the hatched chicks were raised and evaluated at the age of 7 days. In summary, adding lysophospholipid (LPL) to the breeders’ diet led to improved offspring body weight, a better food conversion ratio, and lower blood fat levels. Additionally, it supported liver health and increased the expression of genes associated with lipid processing in both the gut and liver.

Abstract

The present study aimed to investigate whether supplementation of modified lysophospholipids (LPLs) in the diet of broiler breeders can benefit their offspring. A total of 264 49-week-old breeders (Ross 308) were allocated and fed based on a 2 × 2 factorial arrangement with two levels of dietary energy (normal energy = 2800 kcal/kg and low energy = 2760 kcal/kg) and two LPL levels (0 and 0.5 g/kg) for periods of 8 and 12 weeks. The offspring were assessed for growth performance, serum parameters, hepatic antioxidative capability, and expression of genes involved in liver β-oxidation at 7 days old. The LPL inclusion improved (p < 0.01) average body weight (ABW), average daily gain (ADG), and feed conversion ratio (FCR). The offspring of 61-week-old breeders fed with LPL exhibited reduced serum triglyceride levels (p < 0.01) but an increase in hepatic glutathione peroxidase (p < 0.05). The LPL increased (p < 0.001) the mRNA expression of the PGC-1α gene in the liver. Supplementing LPL in low-energy diets resulted in higher FABP1 gene expression (p < 0.05) in the intestine. In conclusion, LPL supplementation in the breeders’ diet improved offspring performance by enhancing fatty acid absorption, hepatic indices, and the expression of genes involved in liver β-oxidation.

1. Introduction

Maternal nutrition has a significant impact on the phenotype of offspring [1]. In birds, embryonic development during incubation depends entirely on the nutrients deposited in the eggs [2]. Nutritional changes in the chick embryo may cause epigenetic modifications, altering gene expression, structure, and function of organs and tissues in offspring [2,3]. It has been reported that the supplemental fatty acids (FA) in the breeders’ diet increased the incorporation of dietary FAs into the egg yolk and, therefore, affected the progeny’s development during incubation [4]. In addition, the FAs in the egg yolk were transferred into the liver of the offspring through the yolk residue by the time of hatching [4,5]. This suggests that the FA composition of the embryo’s tissue and the chicks that hatch rely on the fatty acid profile of the egg yolk [6]. This led us to the concept of maternal supplementation of lysophospholipid (LPL) in the broiler breeders’ diet and its subsequent impact on the offspring.
Exogenous emulsifiers such as LPLs have been included in the diet to promote lipid digestion and absorption in poultry [7,8]. LPLs increase the active surface area of lipids by integrating fatty acids into micelles, allowing the lipase enzyme to efficiently hydrolyze triglyceride molecules into fatty acids and monoglycerides. This process leads to increased dietary lipid digestibility in the duodenum [9,10]. In addition, the integration of LPLs into the phospholipid bilayer of enterocytes increases the permeability and formation of ion channels, resulting in an increased influx of micro and macromolecules through these cells [11,12,13,14]. Altogether, the contribution of LPLs to lipid emulsification coupled with cell membrane modification may lead to improved nutrient absorption [15,16].
By modulating genes involved in β-oxidation, LPL regulates the mechanism of fatty acid utilization and influences tissue inflammation. Specifically, LPL reduces hepatic fatty acid utilization through the downregulation of PPARγ (Peroxisome proliferator-activated receptor gamma) transcription [17] and downstream factors such as the PGC-1α (Peroxisome proliferator-activated receptor gamma coactivator 1 alpha) gene, which is involved in the β-oxidation pathway in hepatic cells [18]. The lipoprotein lipase enzyme facilitates lipolysis and the delivery of fatty acids to apolipoproteins for oxidation in various cell types [19]. Once fatty acids and phospholipids within apolipoproteins enter the cytoplasm of cells, they undergo acylation through LPCAT3 (Lysophosphatidylcholine Acyltransferase 3) [20]. Additionally, carnitine palmitoyl transferase 1 (CPT1), produced by the expression of the CPT1A gene, plays an important role in hepatic triglyceride metabolism. It catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine [21].
It has been reported that the supplementation of LPLs in the diet increases the apparent metabolizable energy and nitrogen retention in broilers [22,23,24,25]. Additionally, subsequent studies [9,25,26,27,28,29] have confirmed that dietary supplementation of LPL positively affected the average daily gain (ADG) and feed conversion ratio (FCR) of broiler chickens fed low-energy diets. Other researchers have also observed the benefits of LPL supplementation for maintaining performance in broilers fed with low energy [15] and low-nitrogen diets [16,25,30]. Furthermore, LPLs such as Lysophosphatidylcholine (LPC) could potentially result in the up-regulation of the pro-inflammatory factors as well as TGF-β and NF-κB, leading to the migration of monocytes and macrophages to the gastrointestinal wall [31].
Despite their beneficial effects, there is limited information available on the effect of LPL inclusion in the broiler breeders’ diet and its subsequent impact on the progeny. On the other hand, the mechanisms involved in lipid metabolism are influenced by many factors, such as breeders’ age [32,33], the energy level of the diet [34,35], and the duration of LPL inclusion. Therefore, the potential effect of dietary energy and the duration of LPL inclusion was taken into account. The current study aims to investigate whether LPL supplementation in the breeders’ diet can benefit newly hatched chick performance, serum parameters, the antioxidative capacity of the liver, and the downstream gene expression changes involved in both hepatic β-oxidation pathway and fatty acid absorption.

2. Materials and Methods

2.1. Bird Husbandry and Dietary Treatments

The experimental procedure was approved by the Guidelines for the Care and Use of Laboratory Animals in Iran [36]. A total of two hundred and sixty-four 49-week-old Ross 308 broiler breeders (240 hens, average body weight 3810 g ± 165 SD, and 24 roosters, average body weight 4690 g ± 181 SD) with similar physiological status were chosen and randomly subjected to experimental treatments for 12 weeks. Birds were placed in a floored house and kept according to the Ross 308 breeder management guide [37].
Breeders were randomly allocated to a 2 × 2 factorial arrangement design with two levels of dietary energy (normal energy = 2800 kcal/kg and low energy = 2760 kcal/kg) and two LPL supplement levels (0 and 0.5 g/kg), and 6 replicates (36 pens in total, each containing 10 hens and 1 rooster).
The dietary treatments were as follows: 1—Normal energy diet (NE, metabolizable energy = 2800 kcal/kg) as the control group; 2—Normal energy diet supplemented with LPL 0.5 g/kg (NE + LPL); 3—Low energy diet (LE, metabolizable energy = 2760 kcal/kg); and 4—Low energy diet supplemented with LPL 0.5 g/kg (LE + LPL).
The LPL supplement (Lipidol®, Pathway Intermediates, Seoul, Republic of Korea) was obtained from soybean lecithin using an exclusive proprietary technology). According to the manufacturer, each kilogram of this lysophospholipid product has a matrix value of 80,000 kcal/kg of ME. The recommended dosage is 0.5 g per kg of feed, which contributes a total of 40 kcal per kg of feed.
On the last 7 consecutive days of weeks 8 and 12 of the experiment, the eggs laid by the breeders were collected twice a day, grouped by pen, and stored in a temperature-controlled room at 16 °C. From each experimental group, a total of 120 high-quality eggs were selected and sent to the hatchery. These eggs were hatched under the ambient conditions of 60 to 65% relative humidity and 37.8 °C temperature, with intermittent rotation. After hatching, the chicks were transferred to the experimental farm in two separate batches (weeks 8 and 12). The healthy chicks, with an average initial body weight of 44 ± 0.5 g, were then transferred to the Isfahan University of Technology research center and placed in a caged house.
In the first hatch (week 8 of the experiment), 86, 92, 93, and 90 chicks (361 chicks in total) were hatched from NE, NE + LPL, LE, and LE + LPL groups, respectively. The healthy chicks were randomly selected and assigned to 36 cages, allocated into 4 groups according to their maternal dietary treatment with 9 replicates (cages) of 10 birds each, and reared for 7 days to assess their performance. In the second hatch (week 12 of the experiment), 92, 93, 104, and 98 chicks (387 chicks in total) were hatched from NE, NE + LPL, LE, and LE + LPL groups, respectively. Similarly, these chicks were randomly selected and assigned to 28 cages, allocated into 4 groups according to their maternal dietary treatment with 7 replicates (cages) of 10 birds each, and reared for 7 days to assess their performance. When assigning chicks, it was ensured that all replicates within each treatment had similar body weights. The remaining offspring of the second hatch were kept separately for assessment of serum parameters, hepatic antioxidative capability, and expression of genes involved in liver β-oxidation at 1 day of age. Chicks from both hatches were raised under the same condition for a week, following the rearing guideline of the Ross 308 broiler management guide [38]. A lighting program of 23 h light plus 1h darkness was applied throughout the experimental period. The house temperature was initially set at 33 °C upon the arrival of the chicks and gradually decreased by 0.5 °C each day until it reached 30 °C on day 7 of the experiment. Chicks were fed a control diet (Table 1) formulated in accordance with the Ross 308 nutrient specifications [39]. The diet was provided using trough feeders, and the chicks had unlimited access to water. At the end of the experimental period, the individual weight of each chick and the total feed intake of each cage were recorded to determine the average daily gain (ADG) and average daily feed intake (ADFI). The feed conversion ratio (FCR) was calculated using the formula: FCR = ADFI (g)/ADG (g). These calculations were performed separately for each cage.

2.2. Sample Collection

On day one, a total of 28 chicks (7 chicks per treatment) hatched from 61-week-old breeders were randomly selected and humanely euthanized by CO2 inhalation for sample collection. Blood samples were collected via cardiac puncture by inserting a heparinized needle through the heart ventricle [40,41,42]. The needle was then removed from the syringe, and the blood was slowly aspirated into micro tubes, followed by centrifugation at 2000× g at 15 °C for 10 min to separate plasma from blood cells [43]. The plasma samples were stored at −20 °C prior to blood profile measurements. To measure the tissue gene expression, tissue samples were taken from the left lobe of the liver, pancreas, and jejunum (a longitudinal segment 5 cm anterior to the Meckel’s diverticulum). All samples were carefully washed with distilled water, immediately frozen in liquid nitrogen, and stored at −80 °C for subsequent analysis. In addition, the entire right lobe of the liver was collected and stored at −20 °C to measure the hepatic antioxidative capability.

2.3. Plasma Parameters and Liver Tissue Analysis

The plasma samples were analyzed for triglyceride (TG), cholesterol, albumin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP). Furthermore, the liver tissue samples were minced and homogenized in an ice-cold 0.9% phosphate-buffered saline solution using a homogenizer (Ultra-Turrax®, IKA Works, Inc., Wilmington, NC, USA). Afterward, the mixture was centrifuged at 4000 RPM for 10 min at 4 °C, and the supernatant was used for measurement of superoxide dismutase (SOD), glutathione peroxidase (GPx), total protein (TP), total antioxidative capacity (TAC), and malondialdehyde (MDA) content. Both plasma and liver tissue samples were analyzed using an automatic analyzer (Alycon 300i, Dual voltage instrument; Abbott Laboratories Ltd., Chicago, IL, USA) with commercial assay kits (Pars Azmun® medical equipment manufacturing, Tehran, Iran).

2.4. Total RNA Extraction

The liver, jejunum, and pancreas tissues were placed separately into a stainless-steel grinding plate with appropriate steel beads, and 1 mL of TRIzol solution was added to each sample. The mixture was ground for 1–2 min. Next, the solution was transferred to a 1.5 mL microtube, and 200 µL chloroform was added to the suspension, followed by vortexing for 1 min. The solutions were then left at room temperature for 20 min and centrifuged at 13,000× g RPM for 15 min at 4 °C. The upper clear phase was transferred to another set of microtubes, followed by the addition of 500 µL isopropanol, and centrifuged at 11,500 RPM for 15 min at 4 °C. The supernatant was removed, and 1 mL of ethanol was added and vortexed until the RNA pellet was separated from the bottom of the microtube and centrifuged at 11,500 RPM for 10 min at 4 °C. Subsequently, the supernatant was removed, and the pellet was left to dry at room temperature. After ensuring that the ethanol has evaporated, diethylpyrocarbonate (DEPC)-treated water was added based on the amount of RNA pellet. RNase-free DNase I (Sinaclon, Tehran, Iran) was used to remove DNA contamination. The total quantity of RNA and purity ratios (260/280 ratios) were calculated using a NanoDrop-2000 (Thermo, Waltham, MA, USA). Finally, the extracted RNA was dissolved and stored at −80 °C for subsequent analysis.

2.5. Primer Design

All primers were designed using Primer 3 Plus online software (https://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi, accessed on 21 March 2021) and checked with the NCBI Primer Blast (https://www.ncbi.nlm.nih.gov/tools/primer-blast/, accessed on 21 March 2021) to confirm the correct targeting of the desired genes (Table 2). The primers were commercially purchased from TAG Co. Copenhagen, Denmark.

2.6. Complementary DNA (cDNA) Synthesis

The cDNAs were synthesized using a random hexamer mix following the manufacturer’s instructions (cDNA Synthesis RT reagent Kit Sinaclon, Tehran, Iran). The resulting cDNA was stored at −20 °C for future experiments.

2.7. Quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR)

The procedures and reagents for the qRT-PCR experiment were conducted as described in our previous publications [44,45,46]. Briefly, the cycle threshold (Ct) values of the triplicate PCRs were averaged, and the relative quantification of the transcript levels was performed using the comparative 2−ΔΔCT method. The fold change in the target gene, relative to GAPDH, was determined according to the following formula: fold change = 2−ΔΔCT, where ΔΔCT = (Ct target gene − Ct GAPDH), ΔCT = CT (a target gene) − CT (a reference gene), ΔΔCT = ΔCT (a target sample) − ΔCT (a reference sample); every sample was further fortified without inverse transcription to ensure that no DNA impurity would be in the sample [47].

2.8. Statistical Analysis

Experimental data was analyzed using SAS software version 9.04 (SAS Institute, Cary, NC, USA) as a 2 × 2 factorial arrangement. Each cage served as the experimental unit. The statistical model used was: Yijk = µ + Mi + Lj + MLij + eijk, where Yijk represents the amount of each observation, µ is the experimental mean, Mi is the effect of metabolizable energy, Lj the effect of LPL supplementation, MLij is the interaction between metabolizable energy level and LPL supplementation level, and eijk is the error term. In simpler terms, the model comprised the main effects of the metabolizable energy level and LPL supplementation level, as well as the interaction between the metabolizable energy level and LPL supplementation level. The normality of the data was checked before conducting the ANOVA analysis. The significance was assessed using the two-way ANOVA analysis, and the Tukey test was used to differentiate between means. A p-value less than 0.05 was considered statistically significant. The data was presented as mean ± SEM for each group.

3. Results and Discussion

3.1. Broiler Performance

Previous research has shown that the level of diet metabolizable energy greatly affects the bird’s growth performance [35]. This energy is utilized by the animal for maintenance and production parameters [48]. Table 3 presents the performance of offspring during the 0–7 day period after hatching from breeders fed dietary treatments for 8 and 12 weeks (57 and 61-week-old). The interaction analysis revealed no significant difference across the dietary treatments. Moreover, the main effects showed that feeding the 57-week-old breeders with the normal energy diets resulted in offspring with superior (p < 0.05) ABW at the end of day 7, as compared to those fed the low energy diets. This suggests that offspring from the low-energy group primarily used energy for maintenance, limiting the energy towards production [48,49]. Previous studies have demonstrated that reducing the energy of a broiler diet significantly impaired birds’ ADG and FCR [25,30,50]. However, there is limited literature available to understand the impact of reducing the dietary metabolizable energy of breeders on the subsequent long-term performance of their offspring to confirm our results. Majdolhosseini et al. (2019) found that broilers fed a diet containing LPL 0.1% and 100 kcal/kg less dietary energy exhibited equivalent FCR and increased apparent digestibility of dry matter, nitrogen, ether extract, and gross energy at 24 d of age compared to the control group [50].
In our study, the ADG of chickens hatched from 57-week-old breeders fed with the low-energy diet tended to be lower (p = 0.07). Additionally, the inclusion of LPL resulted in improved (p < 0.05) ABW, ADG, and FCR in chickens hatched from both hens that fed with LPL for 8 and 12 weeks (57 and 61-week-old, respectively). However, feeding breeders for 12 weeks with 0.5 g/kg of LPL resulted in a greater ADFI of chickens (p = 0.06). These findings could be attributed to the role of the LPL supplement, which acted as an exogenous emulsifier, facilitating the digestion and absorption of lipids [51], and subsequently improved the offspring’s performance via increased fatty acid mobilization to the egg. The benefits of improved ADG and FCR in this study were consistent with the findings of Boontiam et al. (2019), who observed that the inclusion of 0.1% LPL in broilers’ diet could enhance growth performance in young birds from 1 to 21 d of age through the improvements in feed efficiency [16]. Similarly, Zhao and Kim (2017) reported improved growth performance and reduced FCR due to supplementation of LPL in broilers diet from 1 to 28 d of age compared to those fed the basal diet [25]. These findings highlight the vital role of modified LPL in lipid digestion, as it improves nutrient absorption by increasing micelle formation [52].

3.2. Blood Profile

Table 4 represents the serum biochemical parameters of day-old offspring of the second hatch, which fed dietary treatments for 12 weeks (61-week-old). The main effect of metabolizable energy showed that the low-energy diets resulted in decreased (p < 0.05) serum cholesterol compared to the normal energy diets. This is consistent with the findings of Boontiam et al. (2019), who reported reduced serum TG concentration in broilers fed 0.1% LPL supplement [16]. Similar results were detected by Hosseini et al. (2018), who stated that TG and LDL concentrations were decreased by the supplementation of 0.1% LPL in broilers fed with a low-energy diet on d 24 [53]. The faster absorption and metabolism rate of ingested fat may explain the lower serum TG levels in birds fed LPL [9,52]. This indicates that chylomicrons were either secreted into the serum at a slower rate or cleared from the blood at a faster rate [54], reflecting an improved lipid metabolism in the liver [55]. However, this effect needs further investigation since we did not measure the concentration of hepatic lipoproteins and lipid content in the blood and liver. Other possible mechanisms underlying the reduction in blood TG will be discussed using the expression of liver candidate genes. Interestingly, in the current study, the LPL supplement did not alter the serum cholesterol, which is in contrast to previous reports on broiler chickens [25,50,56]. These studies agreed that LPL supplementation in the diet significantly reduced cholesterol levels in serum.
In the present study, the offspring of breeders fed the low-energy diets had elevated (p < 0.05) serum AST compared to the normal energy diets. Feeding breeders with the LPL-containing diets resulted in chicks with a lower serum TG (p < 0.01) and AST (p < 0.01) compared to diets with no LPL supplement. Contrary to our findings, Boontiam et al. (2019) found that reduced metabolizable energy diets, either with or without LPL supplementation, did not significantly alter the AST enzyme activity in broilers. These authors concluded that an energy reduction of not more than 150 kcal/kg is safe for broilers [16]. Aspartate aminotransferase (AST) is a marker of mitochondrial activity in the Kupffer cells, and it is measured in serum to assess body metabolism rate and liver health status [57]. Higher serum AST activity indicates an increased rate of free amino acid utilization by catabolizing the amino acid carbon skeleton [58].
The analysis of output data showed no interactions between dietary treatments, except for the ALP, where the greatest serum ALP was related to the offspring of breeders who were fed the NE + LPL diet. Alkaline phosphatase (ALP) is a serological marker of bone metabolism, which provides a real-time assessment of bone formation, mineralization, and turnover. Although the exact function of ALP is unknown, it is mainly associated with increased osteoblastic activity in breeders and commercial chickens [59,60]. The increase in the ALP level of the NE + LPL group might be due to an increase in corticosteroids, epinephrine, and nor-epinephrine secretion [41]. Contrary to our findings, Lai et al. (2018) confirmed no significant difference in serum ALP activity of 42-day-old male broiler chickens fed with a high dose of bile salts (400 mg/kg) compared to the control group [61]. However, the mechanism responsible for these enzyme activity alterations is difficult to explain and needs further examination. It is crucial to acknowledge that in the present study, the total ALP was measured, which includes contributions from other sources, such as the liver. Therefore, future investigations should measure the bone-specific ALP to achieve a more comprehensive understanding.

3.3. Hepatic Antioxidative Capability

Table 5 demonstrates the hepatic antioxidative capability of day-old offspring of the second hatched, which hatched from breeders fed dietary treatments for 12 weeks (61-week-old). SOD and GPx activity, as well as MDA and TAC levels, are used as markers of oxidant-antioxidant state in animals [62]. Superoxide dismutase (SOD) is a copper and zinc-containing enzyme that helps prevent the buildup of superoxide (O2). The accumulation of superoxide can act as an oxidant by itself, and when combined with H2O2, it forms the OH radical, or it is combined with NO, which forms peroxynitrite [62]. Decreased or inhibited SOD activity may result in cellular membrane damage due to peroxidative processes initiated by the accumulation of free O2 [63,64]. There were significant interactions between dietary energy and LPL supplementation on hepatic SOD (p < 0.01) and MDA (p < 0.05) levels in chickens. Interestingly, the addition of LPL to normal energy diets increased SOD and MDA levels, while its addition to low energy diets decreased SOD and MDA levels. This finding could be referred to as a higher demand for SOD enzyme for lipid metabolism, resulting from the higher absorption rate of fatty acids in the liver caused by LPL. In contrast, Siyal et al. (2017) observed a significant increase in hepatic SOD activity of 42 d old broilers fed with 0.1% soybean lecithin, as compared to the control group [65]. In this study, dietary LPL inclusion at 0.5 g/kg in breeders’ diet led to offspring with reduced hepatic SOD (p < 0.01) and increased hepatic GPx, indicating the improved antioxidant status of chickens [66]. Confirming the present findings, El-katcha et al. (2021) reported that feeding 60-d-old ducks with 0.05% lysolecithin resulted in increased GPx activity [67]. GPx predominantly catalyzes the conversion of H2O2 to H2O. Furthermore, GPx [68] catalyzes the reduction of fatty acid hydroperoxides, which are the primary oxygenated products of polyunsaturated fatty acids, as well as 1-monoacylglycerol hydroperoxides.
MDA and T-AOC are widely used as indicators of oxidative stress in meat [69,70]. Malondialdehyde is a soluble degraded product of lipid peroxidation and an indicator of lipid oxidation intensity in tissues such as the liver, heart, kidney, spleen, lungs, egg, and erythrocytes. Elevated MDA levels in meat are associated with characteristics such as a rotten smell, loss of taste and color, and reduced nutritional value [71]. Our results suggest an increase (p < 0.01) in the offspring’s hepatic MDA level of breeders fed NE + LPL, which could be explained by the fact that the high-energy diet promoted performance in chickens, thus causing higher metabolic stress with an expected increase of MDA [72,73]. In Siyal et al. (2017) study, the hepatic MDA of birds fed with 0.1% soybean lecithin significantly reduced in comparison with the control group, which is in contrast with the findings of the current study [65]. Moreover, Wu et al. (2022) fed day-old goslings with 100 mg/kg soybean lecithin for 32 days and concluded that soybean lecithin supplementation led to a significant decrease in the serum MDA of birds [74].

3.4. Expression of Candidate Genes in the Liver

To test whether the metabolizable energy levels and consumption of LPL by the breeders could influence the gene expression of offspring, we analyzed the expression of candidate genes in the liver, jejunum, and pancreas tissues.
We investigated the transcription of the PPARγ gene in the liver hepatocyte cells of the offspring broilers. There was no significant difference among treatments in mRNA expression for PPARγ. The PPARγ gene is responsible for triacylglycerol storage in the adipose tissue [74]. PPARγ gene expression was not affected by the treatments in the current study since the newly hatched chicks lack adipose tissue.
Reciprocal effects show that the LE diet led to a decrease in PGC-1α gene expression, but the LPL supplementation in both NE and LE diets increased the PGC-1α gene transcription. (p < 0.001). The NE + LPL and the LE + LPL groups showed an increase in PGC-1α expression, as compared to the NE and LE groups (p < 0.05). While the LE group showed a decrease (p < 0.05) in the PGC-1α expression when compared to the other groups (Figure 1(A1)). Several studies have shown that the PGC-1α gene is downstream of the PPARγ gene and, therefore, is affected by the expression of the PPARγ gene. The PGC-1α regulates key mitochondrial genes essential for adaptive thermogenesis and plays a crucial role in metabolic adjustments in response to dietary changes by influencing the transcription of numerous genes involved in nutrient metabolism [75,76]. However, as we observed in the present study, the expression of the PPARγ gene was not affected by any of the treatments, but the PGC-1α gene showed a drastic change in response to LPL supplementation. This indicates that the PGC-1α gene in different tissues can be considered as a gene downstream of other genes [77], as we showed in our previous studies in the C2C12 cell line and gastrointestinal tissue [44,45,46]. Therefore, PGC-1α gene expression was not affected by the increase or decrease in the expression of the PPARγ gene.
Potentially, PGC-1α leads to fatty acid oxidation in the hepatocytes. The PGC-1α gene regulates the production of the C-Ⅱ apolipoprotein, which is involved in the production and secretion of VLDL [77,78]. The main effect of LPL was a significantly decreased serum TG concentration. Therefore, it is possible that LPL supplementation could have caused a positive change in the transcription of PGC-1α, leading to increased production of apolipoproteins. The current study has shown that LPL supplementation regulated the production of pancreatic lipase, which ultimately caused a decrease in triglyceride-related pancreatitis and increased hydrolysis of triglycerides in the intestinal lumen, resulting in better absorption of lipid derivatives [79].
According to the results, LPL increased the expression of the lipoprotein lipase gene in the NE + LPL diet. In contrast, the LE + LPL diet decreased the lipoprotein lipase gene expression compared to the LE diet. The transcription of the Lipoprotein lipase gene significantly increased in all of the groups, as compared to the NE group. The NE + LPL and the LE groups had higher expression among other experimental groups (p < 0.01) (Figure 1B). The basal role of lipoprotein lipase is catalyzing the hydrolysis of the fatty acid component and lipoproteins, therefore providing non-esterified fatty acids for cell usage [80]. The expression of the lipoprotein lipase gene is high in capillaries and also in the liver of newly hatched chickens [81]. Additionally, nutritional and other physiological changes could contribute to the variation in lipoprotein lipase expression [82]. This enzyme needs cofactors such as phospholipids and Apo-protein C-Ⅱ to function [83]. The lipoprotein lipase enzyme causes the hydrolysis of triacylglycerol in the bloodstream, resulting in a reduction of triglycerides in the serum profile. This reduction is partially attributed to the activity of this enzyme [84]. In other words, by providing cofactors for this enzyme, LPL causes more consumption of VLDL and LDL by other tissues, including the liver itself. Therefore, the insignificant differences in PPARγ gene expression among the treatments, besides an increase in PGC-1a and lipoprotein lipase gene expression, result in increased TG usage in the liver and a lack of abdominal fat formation in the broilers.
LPL increased the LPCAT3 transcription in the NE + LPL diet, while in the LE diet, the LPCAT3 gene expression decreased with LPL supplementation. The expression of the LPCAT3 gene increased in NE + LPL and LE birds, compared to the NE group (p < 0.01). Also, the transcription of the LPCAT3 gene in the LE + LPL diet increased when compared to the NE group (p < 0.05) (Figure 1C). The LPC in the intestinal epithelial cells leads to an increment of lipid absorption. During this process, transcription of the LPCAT3 gene is increased, resulting in the re-esterification of LPC to phosphatidylcholine [85]. LPCAT3 also esterifies lysophospholipid species [86], converting 1-acyl LPC to phosphatidylcholine [87], 1-acyl lysophosphatidylserine to phosphatidylserine [88], and 1-acyl lysophosphatidylethanolamine to phosphatidylethanolamine. Moreover, the LPCAT3 gene acts as a major LPC O-acyltransferase in the liver and intestine [89]. It also increases membrane dynamics and enables the transfer of triacylglycerols to nascent, very low-density lipoprotein (VLDL) particles [90]. However, previous studies demonstrated that a reduction of LPCAT3 expression can decrease cholesterol, phospholipids, and plasma TG concentration [91]. Therefore, we expected that the utilization of LPL would increase the LPCAT3 gene expression. Previous studies have shown that reducing the LPCAT3 gene expression can increase the rate of apoptosis in liver cells [85]. The reason could be that by reducing the expression of LPCAT3, the amount of LPC esterification decreases. The amount of storage of fatty acids in liver cells probably increases since LPC is known to be effective in inducing cell death in liver cells [92]. In our study, we observed that the reduction of dietary energy and the inclusion of LPL in the diet increased the LPCAT3 gene transcription, which might have reduced the fatty liver syndrome and apoptosis rate in liver cells.
Based on our results, there was no significant difference in the expression of the RBP gene between dietary treatments. Although the amount of albumin protein remained unchanged across treatments, this may suggest the involvement of free fatty acids in the formation of chylomicrons in intestinal epithelial cells [93]. Moreover, the function of RBP protein depends on pre-albumin, as the RBP-pre-albumin complex transports the absorbed retinol and fatty acids from the liver to the various tissues through the bloodstream. Also, the dietary treatments did not induce any change in albumin and RBP gene expression, which suggests that there was no change in the amount of lipolysis in tissues such as abdominal fat tissue, although newly hatched chickens do not have abdominal fat tissue [94]. However, previous studies have shown that retinol, which regulates RBP gene expression, could potentially activate the transcription of the TGF-β gene. This interaction could prevent various diseases and improve immune system function [95,96]. The CPT1A gene expression response was affected by LPL inclusion in the diet. In the NE + LPL and LE + LPL birds, the transcription of the CPT1A markedly increased, as compared to the NE and LE groups (p < 0.05). However, the inclusion of LPL in both NE and LE diets caused an increase in CPT1A gene expression, while this increase was more visible in the LE + LPL (p < 0.001) (Figure 1D). The protein resulting from the transcription of the CPT1A gene is involved in the pathway of fatty acid beta-oxidation, which is part of lipid metabolism. Carnitine acetyl-transferase enzymes need a sufficient amount of L-carnitine to perform at their best [97]. L-carnitine is supplied through the diet, although it is also produced endogenously in the body from precursors such as lysine and methionine. The high expression of the CPT1A gene under the influence of treatments in all groups compared to the NE group can indicate the proper balance of these two amino acids in the diet. Also, studies have shown that PGC-1α gene transcription acts as an upstream regulator of the CPT1A gene and causes an increase in the CPT1A gene expression [98]. As observed in the present research, adding LPL to the breeders’ diet increased the PGC-1α and, ultimately, CPT1A gene expression in the offspring hepatocytes. While high-fat diets increase the CPT1A gene expression [99], starvation also increases the CPT1A gene expression. Moreover, lipoproteins can also increase the CPT1A gene transcription [100]. Thus, this gene is essential for the mitochondrial uptake of long-chain fatty acids and their subsequent β-oxidation in the mitochondria. Therefore, the CPT1A gene expression can be significantly increased under the influence of genetic factors such as increased expression of PGC-1α and PPAR families, as well as physiological factors such as apolipoproteins and nutritional factors such as dietary fat.

3.5. Expression of Candidate Genes in the Jejunum

The liver fatty acid binding protein, also known as FABP1, is highly expressed in the duodenum and jejunum [101]. Compared to other FABPs, FABP1 has a higher binding capacity for fatty acids and other lipid species, including LPLs [102]. It is also expressed in the intestinal epithelial and hepatocyte cells, where it plays a critical role in lipoprotein-mediated cholesterol uptake [103]. In addition, it binds to sterols [104], bilirubin [105], and free fatty acids [106] and, therefore, is involved in intracellular lipid transport. During fasting, the FABP1 is located on the apical surface of enterocytes [107]. This interaction results in a considerable up-regulation of the FABP1 gene when LPL is supplemented. The addition of LPL in the diets with lower metabolizable energy resulted in the greatest expression of FABP1, as compared to the other groups (p < 0.05). In contrast, the birds fed with NE + LPL did not have a significant difference in the expression of FABP1 relative to the NE and LE groups (Figure 2A). Thus, probably due to the elevated availability of fatty acid during LPL consumption in the lumen, the highest concentration of FABP1 is around the endoplasmic reticulum and Golgi network. Interestingly, the expression of FABP1 is regulated by the PPARs [101]. FABP1 has a positive regulatory effect on fatty acid beta-oxidation and positive regulation of hydrolase activity [108]. Also, the increase in FABP1 expression could lead to overexpression of the liver and intestinal inflammatory genes [109]. It is worth noting that the overload of free fatty acids in the enterocyte after the feeding could be cytotoxic to the enterocyte cells. Thus, the FABP1 protein reduces the apoptotic effect of FFA in the intestinal cells by binding to the FFA [110,111]. The LPL supplementation increased this positive effect of FABP1 through the increment of FABP1 gene transcription [112].
In addition, the transcription of the TGF-β gene did not have any difference between experimental treatments. However, the LE and LE + LPL groups demonstrated a numerical decrease compared to the other groups. Based on our observations, the consumption of NE + LPL diet in the breeders caused an increase in NF-κB gene expression, an inflammatory factor in the offspring intestinal epithelial cells. This is due to the decrease in NF-κB gene expression resulting from the reduction of dietary energy and the volume of free fatty acids in the intestinal epithelial cells. Actually, NF-κB cluster components regulate the transcriptional function of several promoters of pro-inflammatory cytokines [113], immune receptor proteins [114], transcription factors [115], and adhesion factors that contribute to intestinal inflammation [116]. The TGF-β potentially could activate the NF-κB factor. Through the mitochondrial biogenesis increment, the fatty acid β-oxidation changes in the adipocytes, leading to the conversion of the white adipocytes to the brown adipocytes [117].
According to the interaction results, the expression of the NF-κB gene was only increased by adding LPL to the NE diet (p < 0.01). In addition, the main effect of the LPL supplementation was a tendency to increase the transcription of the NF-κB gene. Autotaxin leads to the production of LPA and choline by affecting the LPC [118]. The produced LPA causes oxidative stress, alteration of PPARγ transcription, and mitochondrial dysfunction, probably through the reduction of PGC-1α expression. The LPAs and even LPCs in various tissues, as well as adipocytes, liver, and ovary tissue [119], bind to the G-protein receptors and cause the NF-κB transcriptor activation. Finally, the activated NF-κB induces the expression of pro-inflammatory cytokines, which further stimulate the migration of macrophages and monocytes to the digestive tract, increasing systemic inflammation [120].

3.6. Expression of FABP4 Gene in the Pancreas

The interaction between metabolizable energy and LPL showed that FABP4 gene expression in the offspring was higher in breeders fed with the LE diet (p < 0.01) (Figure 3). Moreover, the main effect of the energy showed that the LE diet had a tendency to increase the transcription of the FABP4 gene (p = 0.08). Also, lysophospholipids could potentially bind to the albumin binding site in the same way as the long-chain fatty acids do [121]. With an increase in fatty acid absorption, the amount of lipoprotein secretion from the liver and the amount of β-oxidation of fatty acids in the mitochondria increases [122]. FABP4 is one of the key factors that demonstrate the abnormal positioning of fat sediment in non-adipose tissues, including the liver [123], and can also regulate enzyme activity [124]. In addition, the FABP4 expression is regulated by the PPARγ [125]. It increases the hydrolytic activity of hormone-sensitive lipase [126], as well as regulating the transcription of PPARγ in the transport of specific PPARγ agonists to the nucleus. As lipolysis increases, the secretion of FABP4 protein from adipocytes also increases. This, in turn, enhances the activity of hormone-sensitive lipase, promoting the defective process and resulting in even more secretion of FABP4 protein [127].

4. Conclusions

Overall, our findings indicate that supplementation of LPL in broiler breeders’ diet with a low energy level favors offspring performance, serum metabolites, and hepatic endurance against oxidative stress. Therefore, the consumption of LPL by breeders improves the health and performance of the offspring, primarily through the regulation of genes involved in the offspring’s liver β-oxidation process. Overall, this study suggests that LPL is a safe and effective feed additive as it enhances lipid absorption and metabolism rate, leading to improved performance and health in poultry.

Author Contributions

M.S.: Supervision, Conceptualization, Methodology, Validation. F.J.: Data Curation, Investigation. A.A.: Data Curation. S.Z.: Writing—Original draft. I.M.: Data Curation, Software. W.K.: Review and editing. and V.S.R.C.: Review and editing. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by Pathway Intermediates Inc. (Seoul, Republic of Korea), grant number 98/128, and Isfahan University of Technology, grant number 9908234. The funder (Pathway Intermediates Inc.) had no role in the study design, data collection, laboratory analysis and interpretation of the data nor writing the manuscript.

Institutional Review Board Statement

The experimental procedure was approved by the Ethics Committee of Isfahan University of Technology, Isfahan, Iran, adhering to Guidelines for the Care and Use of Laboratory Animals in Iran.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study can be accessed by contacting the corresponding author.

Conflicts of Interest

The authors declare that they have no conflicts of interest. There are no competing interests, financial or personal associations with people or organizations that could inappropriately influence this work.

References

  1. Lv, Z.; Fan, H.; Song, B.; Li, G.; Liu, D.; Guo, Y. Supplementing Genistein for Breeder Hens Alters the Fatty Acid Metabolism and Growth Performance of Offsprings by Epigenetic Modification. Oxid. Med. Cell Longev. 2019, 2019, 9214209. [Google Scholar] [CrossRef]
  2. Mennitti, L.V.; Oliveira, J.L.; Morais, C.A.; Estadella, D.; Oyama, L.M.; Oller do Nascimento, C.M.; Pisani, L.P. Type of Fatty Acids in Maternal Diets during Pregnancy and/or Lactation and Metabolic Consequences of the Offspring. J. Nutr. Biochem. 2015, 26, 99–111. [Google Scholar] [CrossRef] [PubMed]
  3. Akbari Moghaddam Kakhki, R.; Ma, D.W.L.; Price, K.R.; Moats, J.; Karrow, N.A.; Kiarie, E.G. Impact of Feeding N-3 Fatty Acids to Layer Breeders and Their Offspring on Concentration of Antibody Titres against Infectious Bronchitis, and Newcastle Diseases and Plasma Fatty Acids in the Offspring. Br. Poult. Sci. 2021, 62, 270–277. [Google Scholar] [CrossRef]
  4. Koppenol, A.; Buyse, J.; Everaert, N.; Willems, E.; Wang, Y.; Franssens, L.; Delezie, E. Transition of Maternal Dietary N-3 Fatty Acids from the Yolk to the Liver of Broiler Breeder Progeny via the Residual Yolk Sac. Poult. Sci. 2015, 94, 43–52. [Google Scholar] [CrossRef] [PubMed]
  5. Koppenol, A.; Delezie, E.; Aerts, J.; Willems, E.; Wang, Y.; Franssens, L.; Everaert, N.; Buyse, J. Effect of the Ratio of Dietary N-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid on Broiler Breeder Performance, Egg Quality, and Yolk Fatty Acid Composition at Different Breeder Ages. Poult. Sci. 2014, 93, 564–573. [Google Scholar] [CrossRef]
  6. Cherian, G. Metabolic and Cardiovascular Diseases in Poultry: Role of Dietary Lipids. Poult. Sci. 2007, 86, 1012–1016. [Google Scholar] [CrossRef] [PubMed]
  7. Maldonado-Valderrama, J.; Wilde, P.; MacIerzanka, A.; MacKie, A. The Role of Bile Salts in Digestion. Adv. Colloid Interface Sci. 2011, 165, 36–46. [Google Scholar] [CrossRef]
  8. Krezhova, D. Recent Trends for Enhancing the Diversity and Quality of Soybean Products; Krezhova, D., Ed.; InTech: Rijeka, Croatia, 2012; ISBN 978-953-307-533-4. [Google Scholar]
  9. Jansen, M.; Nuyens, F.; Buyse, J.; Leleu, S.; Van Campenhout, L. Interaction between Fat Type and Lysolecithin Supplementation in Broiler Feeds. Poult. Sci. 2015, 94, 2506–2515. [Google Scholar] [CrossRef]
  10. Siyal, F.A.; Babazadeh, D.; Wang, C.; Arain, M.A.; Saeed, M.; Ayasan, T.; Zhang, L.; Wang, T. Emulsifiers in the Poultry Industry. Worlds. Poult. Sci. J. 2017, 73, 611–620. [Google Scholar] [CrossRef]
  11. Maingret, F.; Patel, A.J.; Lesage, F.; Lazdunski, M.; Honoré, E. Lysophospholipids Open the Two-Pore Domain Mechano-Gated K+ Channels TREK-1 and TRAAK. J. Biol. Chem. 2000, 275, 10128–10133. [Google Scholar] [CrossRef] [PubMed]
  12. Kelkar, D.A.; Chattopadhyay, A. The Gramicidin Ion Channel: A Model Membrane Protein. Biochim. Biophys. Acta Biomembr. 2007, 1768, 2011–2025. [Google Scholar] [CrossRef]
  13. Lundbæk, J.A.; Collingwood, S.A.; Ingólfsson, H.I.; Kapoor, R.; Andersen, O.S. Lipid Bilayer Regulation of Membrane Protein Function: Gramicidin Channels as Molecular Force Probes. J. R. Soc. Interface 2010, 7, 373–395. [Google Scholar] [CrossRef] [PubMed]
  14. Arouri, A.; Mouritsen, O.G. Membrane-Perturbing Effect of Fatty Acids and Lysolipids. Prog. Lipid Res. 2013, 52, 130–140. [Google Scholar] [CrossRef] [PubMed]
  15. Chen, C.; Jung, B.; Kim, W.K. Effects of Lysophospholipid on Growth Performance, Carcass Yield, Intestinal Development, and Bone Quality in Broilers. Poult. Sci. 2019, 98, 3902–3913. [Google Scholar] [CrossRef]
  16. Boontiam, W.; Hyun, Y.K.; Jung, B.; Kim, Y.Y. Effects of Lysophospholipid Supplementation to Reduced Energy, Crude Protein, and Amino Acid Diets on Growth Performance, Nutrient Digestibility, and Blood Profiles in Broiler Chickens. Poult. Sci. 2019, 98, 6693–6701. [Google Scholar] [CrossRef]
  17. Labonté, E.D.; Pfluger, P.T.; Cash, J.G.; Kuhel, D.G.; Roja, J.C.; Magness, D.P.; Jandacek, R.J.; Tschöp, M.H.; Hui, D.Y. Postprandial Lysophospholipid Suppresses Hepatic Fatty Acid Oxidation: The Molecular Link between Group 1B Phospholipase A 2 and Diet-induced Obesity. FASEB J. 2010, 24, 2516–2524. [Google Scholar] [CrossRef]
  18. Cheng, C.F.; Ku, H.C.; Lin, H. Pgc-1α as a Pivotal Factor in Lipid and Metabolic Regulation. Int. J. Mol. Sci. 2018, 19, 3447. [Google Scholar] [CrossRef] [PubMed]
  19. Fielding, P.E.; Fielding, C.J. Dynamics of Lipoprotein Transport in the Human Circulatory System. In New Comprehensive Biochemistry; Elsevier: Amsterdam, The Netherlands, 2002; Volume 36, pp. 527–552. ISBN 0444511385. [Google Scholar]
  20. Cifarelli, V.; Abumrad, N.A. Enterocyte Fatty Acid Handling Proteins and Chylomicron Formation. In Physiology of the Gastrointestinal Tract, 6th ed.; Elsevier: Amsterdam, The Netherlands, 2018; Volume 2, pp. 1087–1107. ISBN 9780128099544. [Google Scholar]
  21. Wang, M.; Wang, K.; Liao, X.; Hu, H.; Chen, L.; Meng, L.; Gao, W.; Li, Q. Carnitine Palmitoyltransferase System: A New Target for Anti-Inflammatory and Anticancer Therapy? Front. Pharmacol. 2021, 12, 760581. [Google Scholar] [CrossRef]
  22. Kamisoyama, H.; Honda, K.; Kubo, S.; Hasegawa, S. Effects of Dietary Protein Levels on Amino Acid Digestibility at Different Sites of Male Adult Chicken Intestines. J. Poult. Sci. 2010, 47, 220–226. [Google Scholar] [CrossRef]
  23. Raju, D.V.L.N.; Rao, S.V.R.; Chakrabarti, P.P.; Rao, B.V.S.K.; Panda, A.K.; Devi, B.L.A.P.; Sujatha, V.; Reddy, J.R.C.; Sunder, G.S.; Prasad, R.B.N. Rice Bran Lysolecithin as a Source of Energy in Broiler Chicken Diet. Br. Poult. Sci. 2011, 52, 769–774. [Google Scholar] [CrossRef] [PubMed]
  24. Zhang, B.; Haitao, L.; Zhao, D.; Guo, Y.; Barri, A. Effect of Fat Type and Lysophosphatidylcholine Addition to Broiler Diets on Performance, Apparent Digestibility of Fatty Acids, and Apparent Metabolizable Energy Content. Anim. Feed Sci. Technol. 2011, 163, 177–184. [Google Scholar] [CrossRef]
  25. Zhao, P.Y.; Kim, I.H. Effect of Diets with Different Energy and Lysophospholipids Levels on Performance, Nutrient Metabolism, and Body Composition in Broilers. Poult. Sci. 2017, 96, 1341–1347. [Google Scholar] [CrossRef] [PubMed]
  26. Malapure, C.D.; Kawitkar, S.B.; Deshmukh, G.B.; Bendale, L.N.; Patankar, R.B. Influence of Dietary Supplementation of Phospholipids and Lysophospholipids on Performance of Broilers. Indian J. Anim. Nutr. 2011, 28, 316–319. [Google Scholar]
  27. Khonyoung, D.; Yamauchi, K.; Suzuki, K. Influence of Dietary Fat Sources and Lysolecithin on Growth Performance, Visceral Organ Size, and Histological Intestinal Alteration in Broiler Chickens. Livest. Sci. 2015, 176, 111–120. [Google Scholar] [CrossRef]
  28. Zampiga, M.; Meluzzi, A.; Sirri, F. Effect of Dietary Supplementation of Lysophospholipids on Productive Performance, Nutrient Digestibility and Carcass Quality Traits of Broiler Chickens. Ital. J. Anim. Sci. 2016, 15, 521–528. [Google Scholar] [CrossRef]
  29. Polycarpo, G.V.; Burbarelli, M.F.C.; CarÃo, A.C.P.; Merseguel, C.E.B.; Dadalt, J.C.; Maganha, S.R.L.; Sousa, R.L.M.; Cruz-Polycarpo, V.C.; Albuquerque, R. Effects of Lipid Sources, Lysophospholipids and Organic Acids in Maize-Based Broiler Diets on Nutrient Balance, Liver Concentration of Fat-Soluble Vitamins, Jejunal Microbiota and Performance. Br. Poult. Sci. 2016, 57, 788–798. [Google Scholar] [CrossRef] [PubMed]
  30. Papadopoulos, G.A.; Poutahidis, T.; Chalvatzi, S.; Di Benedetto, M.; Hardas, A.; Tsiouris, V.; Georgopoulou, I.; Arsenos, G.; Fortomaris, P.D. Effects of Lysolecithin Supplementation in Low-Energy Diets on Growth Performance, Nutrient Digestibility, Viscosity and Intestinal Morphology of Broilers. Br. Poult. Sci. 2018, 59, 232–239. [Google Scholar] [CrossRef]
  31. Liu, Q.Q.; Huo, H.Y.; Ao, S.; Liu, T.; Yang, L.; Fei, Z.Y.; Zhang, Z.Q.; Ding, L.; Cui, Q.H.; Lin, J.; et al. TGF-Β1-Induced Epithelial-Mesenchymal Transition Increases Fatty Acid Oxidation and OXPHOS Activity via the p-AMPK Pathway in Breast Cancer Cells. Oncol. Rep. 2020, 44, 1206–1215. [Google Scholar] [CrossRef] [PubMed]
  32. Burnham, M.R.; Peebles, E.D.; Gardner, C.W.; Brake, J.; Bruzual, J.J.; Gerard, P.D. Effects of Incubator Humidity and Hen Age on Yolk Composition in Broiler Hatching Eggs from Young Breeders. Poult. Sci. 2001, 80, 1444–1450. [Google Scholar] [CrossRef] [PubMed]
  33. Li, F.; Shan, M.X.; Gao, X.; Yang, Y.; Yang, X.; Zhang, Y.Y.; Hu, J.W.; Shan, A.S.; Cheng, B.J. Effects of Nutrition Restriction of Fat- and Lean-Line Broiler Breeder Hens during the Laying Period on Offspring Performance, Blood Biochemical Parameters, and Hormone Levels. Domest. Anim. Endocrinol. 2019, 68, 73–82. [Google Scholar] [CrossRef]
  34. Blanch, A.; Barroeta, A.C.; Baucells, M.D.; Serrano, X.; Puchal, F. Utilization of Different Fats and Oils by Adult Chickens as a Source of Energy, Lipid and Fatty Acids. Anim. Feed Sci. Technol. 1996, 61, 335–342. [Google Scholar] [CrossRef]
  35. Wiseman, J.; Lewis, C.E. Influence of Dietary Energy and Nutrient Concentration on the Growth of Body Weight and of Carcass Components of Broiler Chickens. J. Agric. Sci. 1998, 131, 361–371. [Google Scholar] [CrossRef]
  36. Ahmadi-Noorbakhsh, S.; Mirabzadeh Ardakani, E.; Sadighi, J.; Aldavood, S.J.; Farajli Abbasi, M.; Farzad-Mohajeri, S.; Ghasemi, A.; Sharif-Paghaleh, E.; Hatami, Z.; Nikravanfard, N.; et al. Guideline for the Care and Use of Laboratory Animals in Iran. Lab Anim. 2021, 50, 303–305. [Google Scholar] [CrossRef] [PubMed]
  37. Aviagen. Ross 308. In Parent Stock Handbook; Aviagen: Huntsville, AL, USA, 2020. [Google Scholar]
  38. Aviagen. Ross 308. In Broiler Management Guide; Aviagen: Huntsville, AL, USA, 2020. [Google Scholar]
  39. Aviagen. Ross 308. In Nutrition Specifications; Aviagen: Huntsville, AL, USA, 2020. [Google Scholar]
  40. Parasuraman, S.; Raveendran, R.; Kesavan, R. Blood Sample Collection in Small Laboratory Animals. J. Pharmacol. Pharmacother. 2010, 1, 87–93. [Google Scholar] [CrossRef]
  41. Al-Daraji, H.J.; Amen, M.H.M. Effect of Dietary Zinc on Certain Blood Traits of Broiler Breeder Chickens. Int. J. Poult. Sci. 2011, 10, 807–813. [Google Scholar] [CrossRef]
  42. Lu, L.; Dong, X.; Ma, X.; Zhang, L.; Li, S.; Luo, X.; Liao, X. Metabolic Utilization of Intravenously Injected Iron from Different Iron Sources in Target Tissues of Broiler Chickens. Anim. Nutr. 2022, 9, 74–83. [Google Scholar] [CrossRef] [PubMed]
  43. Snyder, A.M.; Riley, S.P.; Robison, C.I.; Karcher, D.M.; Wickware, C.L.; Johnson, T.A.; Weimer, S.L. Behavior and Immune Response of Conventional and Slow-Growing Broilers to Salmonella Typhimurium. Front. Physiol. 2022, 13, 890848. [Google Scholar] [CrossRef] [PubMed]
  44. Mohammadi, I.; Mahdavi, A.H.; Rabiee, F.; Nasr Esfahani, M.H.; Ghaedi, K. Positive Effects of Conjugated Linoleic Acid (CLA) on the PGC1-α Expression under the Inflammatory Conditions Induced by TNF-α in the C2C12 Cell Line. Gene 2020, 735, 144394. [Google Scholar] [CrossRef]
  45. Sarrami, Z.; Sedghi, M.; Mohammadi, I.; Kim, W.K.; Mahdavi, A.H. Effects of Bacteriophage Supplement on the Growth Performance, Microbial Population, and PGC-1α and TLR4 Gene Expressions of Broiler Chickens. Sci. Rep. 2022, 12, 14391. [Google Scholar] [CrossRef]
  46. Sedghi, M.; Mohammadi, I.; Sarrami, Z.; Ghasemi, R.; Azarfar, A. Effects of a Yeast Cell Wall Product on the Performance of Broiler Chickens and PGC-1α, TLR4, IL-10 and PPARγ Genes Expression. Ital. J. Anim. Sci. 2022, 21, 263–278. [Google Scholar] [CrossRef]
  47. Livak, K.J.; Schmittgen, T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
  48. Al-Marzooqi, W.; Leeson, S. Evaluation of Dietary Supplements of Lipase, Detergent, and Crude Porcine Pancreas on Fat Utilization by Young Broiler Chicks. Poult. Sci. 1999, 78, 1561–1566. [Google Scholar] [CrossRef] [PubMed]
  49. Attia, Y.A.; El-Hamid, A.E.A.; Abdallah, A.A.; Berikaa, M.A.; El-Gandy, M.F.; Sahin, K.; Abou-Shehema, B.M.; von Einfluss, B. Vitamin C und Vitamin E Auf Die Eiqualität, Den Bruterfolg und Ausgewählte Indikatoren Der Lebe—Und Nierenfunktion Bei Unter Hitzestress Gehaltenen Legehennen Des Zweinutzungstyps; Verlag Eugen Ulmer: Stuttgart, Germany, 2018; Volume 82. [Google Scholar]
  50. Majdolhosseini, L.; Ghasemi, H.A.; Hajkhodadadi, I.; Moradi, M.H. Nutritional and Physiological Responses of Broiler Chickens to Dietary Supplementation with De-Oiled Soyabean Lecithin at Different Metabolisable Energy Levels and Various Fat Sources. Br. J. Nutr. 2019, 122, 863–872. [Google Scholar] [CrossRef] [PubMed]
  51. Boontiam, W.; Jung, B.; Kim, Y.Y. Effects of Lysophospholipid Supplementation to Lower Nutrient Diets on Growth Performance, Intestinal Morphology, and Blood Metabolites in Broiler Chickens. Poult. Sci. 2017, 96, 593–601. [Google Scholar] [CrossRef]
  52. Attia, Y.A.; Hussein, A.S.; Tag El-Din, A.E.; Qota, E.M.; Abed El-Ghany, A.I.; El-Sudany, A.M. Improving Productive and Reproductive Performance of Dual-Purpose Crossbred Hens in the Tropics by Lecithin Supplementation. Trop. Anim. Health Prod. 2009, 41, 461–475. [Google Scholar] [CrossRef] [PubMed]
  53. Hosseini, S.M.; Nourmohammadi, R.; Nazarizadeh, H.; Latshaw, J.D. Effects of Lysolecithin and Xylanase Supplementation on the Growth Performance, Nutrient Digestibility and Lipogenic Gene Expression in Broilers Fed Low-Energy Wheat-Based Diets. J. Anim. Physiol. Anim. Nutr. 2018, 102, 1564–1573. [Google Scholar] [CrossRef] [PubMed]
  54. Jones, D.B.; Hancock, J.D.; Harmon, D.L.; Walker, C.E. Effects of Exogenous Emulsifiers and Fat Sources on Nutrient Digestibility, Serum Lipids, and Growth Performance in Weanling Pigs. J. Anim. Sci. 1992, 70, 3473–3482. [Google Scholar] [CrossRef] [PubMed]
  55. Tompkins, R.K.; Parkin, L.G. Effects of Long-Term Ingestion of Soya Phospholipids on Serum Lipids in Humans. Am. J. Surg. 1980, 140, 360–364. [Google Scholar] [CrossRef]
  56. Roy, A.; Haldar, S.; Mondal, S.; Ghosh, T.K. Effects of Supplemental Exogenous Emulsifier on Performance, Nutrient Metabolism, and Serum Lipid Profile in Broiler Chickens. Vet. Med. Int. 2010, 2010, 262604. [Google Scholar] [CrossRef] [PubMed]
  57. Silvia Sookoian, C.J.P. Liver Enzymes, Metabolomics and Genome-Wide Association Studies: From Systems Biology to the Personalized Medicine. World J. Gastroenterol. 2015, 21, 711–725. [Google Scholar] [CrossRef] [PubMed]
  58. Sizova, E.; Miroshnikov, S.; Lebedev, S.; Usha, B.; Shabunin, S. Use of Nanoscale Metals in Poultry Diet as a Mineral Feed Additive. Anim. Nutr. 2020, 6, 185–191. [Google Scholar] [CrossRef] [PubMed]
  59. Harris, H. The Human Alkaline Phosphatases: What We Know and What We Don’t Know. Clin. Chim. Acta 1990, 186, 133–150. [Google Scholar] [CrossRef] [PubMed]
  60. Seibel, M.J. Biochemical Markers of Bone Turnover: Part I: Biochemistry and Variability. Clin. Biochem. Rev. 2005, 26, 97–122. [Google Scholar]
  61. Lai, W.; Cao, A.; Li, J.; Zhang, W.; Zhang, L. Effect of High Dose of Bile Acids Supplementation in Broiler Feed on Growth Performance, Clinical Blood Metabolites, and Organ Development. J. Appl. Poult. Res. 2018, 27, 532–539. [Google Scholar] [CrossRef]
  62. Pereira, A.C.D.S.; Dionísio, A.P.; Wurlitzer, N.J.; Alves, R.E.; De Brito, E.S.; Silva, A.M.D.O.E.; Brasil, I.M.; Mancini Filho, J. Effect of Antioxidant Potential of Tropical Fruit Juices on Antioxidant Enzyme Profiles and Lipid Peroxidation in Rats. Food Chem. 2014, 157, 179–185. [Google Scholar] [CrossRef]
  63. Pryor, W.A.; Houk, K.N.; Foote, C.S.; Fukuto, J.M.; Ignarro, L.J.; Squadrito, G.L.; Davies, K.J.A. Free Radical Biology and Medicine: It’s a Gas, Man! Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 291, R491–R511. [Google Scholar] [CrossRef] [PubMed]
  64. Kokoszka, J.E.; Coskun, P.; Esposito, L.A.; Wallace, D.C. Increased Mitochondrial Oxidative Stress in the Sod2 (+/-) Mouse Results in the Age-Related Decline of Mitochondrial Function Culminating in Increased Apoptosis. Proc. Natl. Acad. Sci. USA 2001, 98, 2278–2283. [Google Scholar] [CrossRef]
  65. Siyal, F.A.; El-Hack, M.E.A.; Alagawany, M.; Wang, C.; Wan, X.; He, J.; Wang, M.; Zhang, L.; Zhong, X.; Wang, T.; et al. Effect of Soy Lecithin on Growth Performance, Nutrient Digestibility and Hepatic Antioxidant Parameters of Broiler Chickens. Int. J. Pharmacol. 2017, 13, 396–402. [Google Scholar] [CrossRef]
  66. Surai, P.F.; Kochish, I.I.; Fisinin, V.I. Glutathione Peroxidases in Poultry Biology: Part 1. Classification and Mechanisms of Action. Worlds. Poult. Sci. J. 2018, 74, 185–197. [Google Scholar] [CrossRef]
  67. El-katcha, M.I.; Soltan, M.A.; Shewita, R.; Abdo, S.E.; Sanad, A.S.; Tufarelli, V.; Alagawany, M.; El-naggar, K. Dietary Fiber and Lysolecithin Supplementation in Growing Ducks: Effect on Performance, Immune Response, Intestinal Morphology and Lipid Metabolism-regulating Genes. Animals 2021, 11, 2873. [Google Scholar] [CrossRef] [PubMed]
  68. Thomas, J.P.; Maiorino, M.; Ursini, F.; Girotti, A.W. Protective Action of Phospholipid Hydroperoxide Glutathione Peroxidase against Membrane-Damaging Lipid Peroxidation. In Situ Reduction of Phospholipid and Cholesterol Hydroperoxides. J. Biol. Chem. 1990, 265, 454–461. [Google Scholar] [CrossRef] [PubMed]
  69. Mahmoud, K.Z.; Hijazi, A.A. Effect of Vitamin A and/or e on Plasma Enzymatic Antioxidant Systems and Total Antioxidant Capacity of Broiler Chickens Challenged with Carbon Tetrachloride. J. Anim. Physiol. Anim. Nutr. 2007, 91, 333–340. [Google Scholar] [CrossRef] [PubMed]
  70. Yin, B.; Tang, S.; Sun, J.; Zhang, X.; Xu, J.; Di, L.; Li, Z.; Hu, Y.; Bao, E. Vitamin C and Sodium Bicarbonate Enhance the Antioxidant Ability of H9C2 Cells and Induce HSPs to Relieve Heat Stress. Cell Stress Chaperones 2018, 23, 735–748. [Google Scholar] [CrossRef]
  71. Raharjo, S.; Sofos, J.N. Methodology for Measuring Malonaldehyde as a Product of Lipid Peroxidation in Muscle Tissues: A Review. Meat Sci. 1993, 35, 145–169. [Google Scholar] [CrossRef]
  72. Miles, R.D.; Butcher, G.D.; Henry, P.R.; Littell, R.C. Effect of Antibiotic Growth Promoters on Broiler Performance, Intestinal Growth Parameters, and Quantitative Morphology. Poult. Sci. 2006, 85, 476–485. [Google Scholar] [CrossRef] [PubMed]
  73. Hashemi Jabali, N.S.; Mahdavi, A.H.; Ansari Mahyari, S.; Sedghi, M.; Akbari Moghaddam Kakhki, R. Effects of Milk Thistle Meal on Performance, Ileal Bacterial Enumeration, Jejunal Morphology and Blood Lipid Peroxidation in Laying Hens Fed Diets with Different Levels of Metabolizable Energy. J. Anim. Physiol. Anim. Nutr. 2018, 102, 410–420. [Google Scholar] [CrossRef]
  74. Wu, H.; Wang, S.; Tian, Y.; Zhou, N.; Wu, C.; Li, R.; Xu, W.; Xu, T.; Gu, L.; Ji, F.; et al. Effects of Hydroxylated Lecithin on Growth Performance, Serum Enzyme Activity, Hormone Levels Related to Lipid Metabolism and Meat Quality in Jiangnan White Goslings. Front. Vet. Sci. 2022, 9, 829338. [Google Scholar] [CrossRef]
  75. Chen, X.; Wu, B.; Shen, X.R.; Wang, X.; Ping, P.; Miao, M.; Liang, N.; Yin, H.; Shi, H.; Qian, J.; et al. Relevance of PUFA-Derived Metabolites in Seminal Plasma to Male Infertility. Front. Endocrinol. 2023, 14, 1138984. [Google Scholar] [CrossRef] [PubMed]
  76. Dominy, J.E.; Lee, Y.; Gerhart-Hines, Z.; Puigserver, P. Nutrient-Dependent Regulation of PGC-1α’s Acetylation State and Metabolic Function through the Enzymatic Activities of Sirt1/GCN5. Biochim. Biophys. Acta Proteins Proteom. 2010, 1804, 1676–1683. [Google Scholar] [CrossRef]
  77. Guan, M.; Qu, L.; Tan, W.; Chen, L.; Wong, C.W. Hepatocyte Nuclear Factor-4 Alpha Regulates Liver Triglyceride Metabolism in Part through Secreted Phospholipase A2 GXIIB. Hepatology 2011, 53, 458–466. [Google Scholar] [CrossRef] [PubMed]
  78. Rhee, J. Partnership of HNF4α with the Transcriptional Coactivator PGC-1α in the Regulation of Hepatic Glucose and Lipid Homeostasis. Ph.D. Thesis, Harvard University, Cambridge, MA, USA, 2005. [Google Scholar]
  79. Haemmerle, G.; Moustafa, T.; Woelkart, G.; Büttner, S.; Schmidt, A.; Van De Weijer, T.; Hesselink, M.; Jaeger, D.; Kienesberger, P.C.; Zierler, K.; et al. ATGL-Mediated Fat Catabolism Regulates Cardiac Mitochondrial Function via PPAR-Î ± and PGC-1. Nat. Med. 2011, 17, 1076–1085. [Google Scholar] [CrossRef]
  80. Mead, J.R.; Irvine, S.A.; Ramji, D.P. Lipoprotein Lipase: Structure, Function, Regulation, and Role in Disease. J. Mol. Med. 2002, 80, 753–769. [Google Scholar] [CrossRef] [PubMed]
  81. Boonsinchai, N. Effect of Feeding Regimen and Age on Lipid Metabolism in Broiler Breeder Hens and Progeny. Ph.D. Thesis, University of Arkansas, Fayetteville, AR, USA, 2015. [Google Scholar]
  82. Shang, R.; Rodrigues, B. Lipoprotein Lipase and Its Delivery of Fatty Acids to the Heart. Biomolecules 2021, 11, 1016. [Google Scholar] [CrossRef]
  83. Kumari, A.; Kristensen, K.K.; Ploug, M.; Lund Winther, A.M. The Importance of Lipoprotein Lipase Regulation in Atherosclerosis. Biomedicines 2021, 9, 782. [Google Scholar] [CrossRef] [PubMed]
  84. Havel, R.J.; Fielding, C.J.; Olivecrona, T.; Shore, V.G.; Fielding, P.E.; Egelrud, T. Cofactor Activity of Protein Components of Human Very Low Density Lipoproteins in the Hydrolysis of Triglycerides by Lipoprotein Lipase from Different Sources. Biochemistry 1973, 12, 1828–1833. [Google Scholar] [CrossRef] [PubMed]
  85. Shao, G.; Qian, Y.; Lu, L.; Liu, Y.; Wu, T.; Ji, G.; Xu, H. Research Progress in the Role and Mechanism of LPCAT3 in Metabolic Related Diseases and Cancer. J. Cancer 2022, 19, 2430–2439. [Google Scholar] [CrossRef]
  86. Jian, S.; Zhang, X.; Khandelwal, P.J.; Saunders, A.J.; Cumminmgs, B.S.; Oelkers, P. Characterization of Human Lysophospholipid Acyltransferase 3. J. Lipid Res. 2009, 50, 1563–1570. [Google Scholar] [CrossRef]
  87. Matsuda, S.; Inoue, T.; Lee, H.C.; Kono, N.; Tanaka, F.; Gengyo-Ando, K.; Mitani, S.; Arai, H. Member of the Membrane-Bound O-Acyltransferase (MBOAT) Family Encodes a Lysophospholipid Acyltransferase with Broad Substrate Specificity. Genes Cells 2008, 13, 879–888. [Google Scholar] [CrossRef]
  88. Gijón, M.A.; Riekhof, W.R.; Zarini, S.; Murphy, R.C.; Voelker, D.R. Lysophospholipid Acyltransferases and Arachidonate Recycling in Human Neutrophils. J. Biol. Chem. 2008, 283, 30235–30245. [Google Scholar] [CrossRef] [PubMed]
  89. Rong, X.; Wang, B.; Dunham, M.M.; Hedde, P.N.; Wong, J.S.; Gratton, E.; Young, S.G.; Ford, D.A.; Tontonoz, P. Lpcat3-Dependent Production of Arachidonoyl Phospholipids Is a Key Determinant of Triglyceride Secretion. eLife 2015, 4, e06557. [Google Scholar] [CrossRef] [PubMed]
  90. Li, Z.; Ding, T.; Pan, X.; Li, Y.; Li, R.; Sanders, P.E.; Kuo, M.S.; Hussain, M.M.; Cao, G.; Jiang, X.C. Lysophosphatidylcholine Acyltransferase 3 Knockdown-Mediated Liver Lysophosphatidylcholine Accumulation Promotes Very Low Density Lipoprotein Production by Enhancing Microsomal Triglyceride Transfer Protein Expression. J. Biol. Chem. 2012, 287, 20122–20131. [Google Scholar] [CrossRef] [PubMed]
  91. Myoung, S.H.; Sun, Y.P.; Shinzawa, K.; Kim, S.; Kun, W.C.; Lee, J.H.; Choon, H.K.; Lee, K.W.; Lee, J.H.; Cheol, K.P.; et al. Lysophosphatidylcholine as a Death Effector in the Lipoapoptosis of Hepatocytes. J. Lipid Res. 2008, 49, 84–97. [Google Scholar] [CrossRef]
  92. Feingold, K.R.; Anawalt, B.; Blackman, M.R.; Boyce, A.; Chrousos, G.; Corpas, E.; de Herder, W.W.; Dhatariya, K.; Dungan, K.; Hofland, J.; et al. Introduction to Lipids and Lipoproteins. In Endotext; MDText.com, Inc.: South Dartmouth, MA, USA, 2000. [Google Scholar]
  93. Edwards, M.; Mohiuddin, S.S. Biochemistry, Lipolysis. In StatPearls; StatPearls Publishing: Treasure Islan, FL, USA, 2022. [Google Scholar]
  94. Choi, Y.; Fuchs, E. TGF-β and Retinoic Acid: Regulators of Growth and Modifiers of Differentiation in Human Epidermal Cells. Mol. Biol. Cell 1990, 1, 791–809. [Google Scholar] [CrossRef] [PubMed]
  95. Xu, Q.; Kopp, J.B. Retinoid and TGF-β Families: Crosstalk in Development, Neoplasia, Immunity, and Tissue Repair. Semin. Nephrol. 2012, 32, 287–294. [Google Scholar] [CrossRef] [PubMed]
  96. Schlaepfer, I.R.; Joshi, M. CPT1A-Mediated Fat Oxidation, Mechanisms, and Therapeutic Potential. Endocrinol. 2020, 161, bqz046. [Google Scholar] [CrossRef]
  97. Du, Q.; Tan, Z.; Shi, F.; Tang, M.; Xie, L.; Zhao, L.; Li, Y.; Hu, J.; Zhou, M.; Bode, A.; et al. PGC1α/CEBPB/CPT1A Axis Promotes Radiation Resistance of Nasopharyngeal Carcinoma through Activating Fatty Acid Oxidation. Cancer Sci. 2019, 110, 2050–2062. [Google Scholar] [CrossRef]
  98. Moody, L.; Xu, G.B.; Chen, H.; Pan, Y.X. Epigenetic Regulation of Carnitine Palmitoyltransferase 1 (Cpt1a) by High Fat Diet. Biochim. Biophys. Acta Gene Regul. Mech. 2019, 1862, 141–152. [Google Scholar] [CrossRef] [PubMed]
  99. Fontaine, M.; Dessein, A.F.; Douillard, C.; Dobbelaere, D.; Brivet, M.; Boutron, A.; Zater, M.; Mention-Mulliez, K.; Martin-Ponthieu, A.; Vianey-Saban, C.; et al. A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency. JIMD Rep. Case Res. Rep. 2012, 6, 7–14. [Google Scholar] [CrossRef]
  100. Frazier-Wood, A.C.; Aslibekyan, S.; Absher, D.M.; Hopkins, P.N.; Sha, J.; Tsai, M.Y.; Tiwari, H.K.; Waite, L.L.; Zhi, D.; Arnett, D.K. Methylation at CPT1A Locus Is Associated with Lipoprotein Subfraction Profi Les. J. Lipid Res. 2014, 55, 1324–1330. [Google Scholar] [CrossRef]
  101. Chen, Y.; Agellon, L.B. Distinct Alteration of Gene Expression Programs in the Small Intestine of Male and Female Mice in Response to Ablation of Intestinal Fabp Genes. Genes 2020, 11, 943. [Google Scholar] [CrossRef] [PubMed]
  102. Storch, J.; Corsico, B. The Emerging Functions and Mechanisms of Mammalian Fatty Acid-Binding Proteins. Annu. Rev. Nutr. 2008, 28, 73–95. [Google Scholar] [CrossRef]
  103. Rodriguez Sawicki, L.; Bottasso Arias, N.M.; Scaglia, N.; Falomir Lockhart, L.J.; Franchini, G.R.; Storch, J.; Córsico, B. FABP1 Knockdown in Human Enterocytes Impairs Proliferation and Alters Lipid Metabolism. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2017, 1862, 1587–1594. [Google Scholar] [CrossRef] [PubMed]
  104. Nemecz, G.; Schroeder, F. Selective Binding of Cholesterol by Recombinant Fatty Acid Binding Proteins. J. Biol. Chem. 1991, 266, 17180–17186. [Google Scholar] [CrossRef] [PubMed]
  105. Gordon, D.M.; Neifer, K.L.; Hamoud, A.R.A.; Hawk, C.F.; Nestor-Kalinoski, A.L.; Miruzzi, S.A.; Morran, M.P.; Adeosun, S.O.; Sarver, J.G.; Erhardt, P.W.; et al. Bilirubin Remodels Murine White Adipose Tissue by Reshaping Mitochondrial Activity and the Coregulator Profile of Peroxisome Proliferator-Activated Receptor A. J. Biol. Chem. 2020, 295, 9804–9822. [Google Scholar] [CrossRef] [PubMed]
  106. Furuhashi, M.; Hotamisligil, G.S. Fatty Acid-Binding Proteins: Role in Metabolic Diseases and Potential as Drug Targets. Nat. Rev. Drug Discov. 2008, 7, 489–503. [Google Scholar] [CrossRef] [PubMed]
  107. Gajda, A.M.; Storch, J. Enterocyte Fatty Acid-Binding Proteins (FABPs): Different Functions of Liver and Intestinal FABPs in the Intestine. Prostaglandins Leukot. Essent. Fat. Acids 2015, 93, 9–16. [Google Scholar] [CrossRef]
  108. Patterson, E.; Wall, R.; Lisai, S.; Ross, R.P.; Dinan, T.G.; Cryan, J.F.; Fitzgerald, G.F.; Banni, S.; Quigley, E.M.; Shanahan, F.; et al. Bifidobacterium Breve with α-Linolenic Acid Alters the Composition, Distribution and Transcription Factor Activity Associated with Metabolism and Absorption of Fat. Sci. Rep. 2017, 7, 43300. [Google Scholar] [CrossRef] [PubMed]
  109. Porras, D.; Nistal, E.; Martínez-Flórez, S.; Pisonero-Vaquero, S.; Olcoz, J.L.; Jover, R.; González-Gallego, J.; García-Mediavilla, M.V.; Sánchez-Campos, S. Protective Effect of Quercetin on High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice Is Mediated by Modulating Intestinal Microbiota Imbalance and Related Gut-Liver Axis Activation. Free Radic. Biol. Med. 2017, 102, 188–202. [Google Scholar] [CrossRef] [PubMed]
  110. Listenberger, L.L.; Ory, D.S.; Schaffer, J.E. Palmitate-Induced Apoptosis Can Occur through a Ceramide-Independent Pathway. J. Biol. Chem. 2001, 276, 14890–14895. [Google Scholar] [CrossRef]
  111. Atshaves, B.P.; Martin, G.G.; Hostetler, H.A.; McIntosh, A.L.; Kier, A.B.; Schroeder, F. Liver Fatty Acid-Binding Protein and Obesity. J. Nutr. Biochem. 2010, 21, 1015–1032. [Google Scholar] [CrossRef]
  112. Kazantzis, M.; Stahl, A. Fatty Acid Transport Proteins, Implications in Physiology and Disease. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2012, 1821, 852–857. [Google Scholar] [CrossRef] [PubMed]
  113. Oeckinghaus, A.; Ghosh, S. The NF-KappaB Family of Transcription Factors and Its Regulation. Cold Spring Harb. Perspect. Biol. 2009, 1, a000034. [Google Scholar] [CrossRef] [PubMed]
  114. Wullaert, A.; Bonnet, M.C.; Pasparakis, M. NF-ΚB in the Regulation of Epithelial Homeostasis and Inflammation. Cell Res. 2011, 21, 146–158. [Google Scholar] [CrossRef] [PubMed]
  115. Giuliani, C.; Bucci, I.; Napolitano, G. The Role of the Transcription Factor Nuclear Factor-Kappa B in Thyroid Autoimmunity and Cancer. Front. Endocrinol. 2018, 9, 471. [Google Scholar] [CrossRef]
  116. Priya, S.S.; Jha, A.; Satish Kumar, R.C.; Sabarathinam, S. The Role of Guggulsterone on the NF-ΚB Pathway in Inflammatory Bowel Disease: Preclinical Evidence. Futur. Sci. OA 2022, 8, FSO803. [Google Scholar] [CrossRef] [PubMed]
  117. Yadav, H.; Rane, S.G. TGF-β/Smad3 Signaling Regulates Brown Adipocyte Induction in White Adipose Tissue. Front. Endocrinol. 2012, 3, 19250. [Google Scholar] [CrossRef] [PubMed]
  118. Nakanaga, K.; Hama, K.; Aoki, J. Autotaxin-An LPA Producing Enzyme with Diverse Functions. J. Biochem. 2010, 148, 13–24. [Google Scholar] [CrossRef] [PubMed]
  119. D’Souza, K.; Paramel, G.V.; Kienesberger, P.C. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance. Nutrients 2018, 10, 399. [Google Scholar] [CrossRef] [PubMed]
  120. Liu, T.; Zhang, L.; Joo, D.; Sun, S.C. NF-ΚB Signaling in Inflammation. Signal Transduct. Target. Ther. 2017, 2, 17023. [Google Scholar] [CrossRef] [PubMed]
  121. Thumser, A.E.A.; Voysey, J.E.; Wilton, D.C. The Binding of Lysophospholipids to Rat Liver Fatty Acid-Binding Protein and Albumin. Biochem. J. 1994, 301, 801–806. [Google Scholar] [CrossRef] [PubMed]
  122. Alves-Bezerra, M.; Cohen, D.E. Triglyceride Metabolism in the Liver. Compr. Physiol. 2018, 8, 1–8. [Google Scholar] [CrossRef]
  123. Rodríguez-Calvo, R.; Moreno-Vedia, J.; Girona, J.; Ibarretxe, D.; Martínez-Micaelo, N.; Merino, J.; Plana, N.; Masana, L. Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk. Front. Physiol. 2021, 12, 781789. [Google Scholar] [CrossRef]
  124. Furuhashi, M.; Saitoh, S.; Shimamoto, K.; Miura, T. Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clin. Med. Insights Cardiol. 2014, 8 (Suppl. S3), 23–33. [Google Scholar] [CrossRef] [PubMed]
  125. Lamas Bervejillo, M.; Bonanata, J.; Franchini, G.R.; Richeri, A.; Marqués, J.M.; Freeman, B.A.; Schopfer, F.J.; Coitiño, E.L.; Córsico, B.; Rubbo, H.; et al. A FABP4-PPARγ Signaling Axis Regulates Human Monocyte Responses to Electrophilic Fatty Acid Nitroalkenes. Redox Biol. 2020, 29, 101376. [Google Scholar] [CrossRef] [PubMed]
  126. Ahmad, F.; Chung, Y.W.; Tang, Y.; Hockman, S.C.; Liu, S.; Khan, Y.; Huo, K.; Billings, E.; Amar, M.J.; Remaley, A.T.; et al. Phosphodiesterase 3B (PDE3B) Regulates NLRP3 Inflammasome in Adipose Tissue. Sci. Rep. 2016, 6, 28056. [Google Scholar] [CrossRef] [PubMed]
  127. Korbecki, J.; Bajdak-Rusinek, K. The Effect of Palmitic Acid on Inflammatory Response in Macrophages: An Overview of Molecular Mechanisms. Inflamm. Res. 2019, 68, 915–932. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The interaction and the main effect of energy and LPL supplement on the transcription of the related genes with β-oxidation in the liver tissue. (A1) Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). (A2) The main effect of LPL supplement on the PGC-1α transcription. (B) Lipoprotein lipase (LPL). (C) Lysophosphatidylcholine acyltransferase 3 (LPCAT3). (D) Carnitine palmitoyltransferase 1A (CPT1A). Whiskers represent SEM. abcd Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise comparison. NE: normal energy, LE: low energy, LPL: Lysophospholipid supplementation.
Figure 1. The interaction and the main effect of energy and LPL supplement on the transcription of the related genes with β-oxidation in the liver tissue. (A1) Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). (A2) The main effect of LPL supplement on the PGC-1α transcription. (B) Lipoprotein lipase (LPL). (C) Lysophosphatidylcholine acyltransferase 3 (LPCAT3). (D) Carnitine palmitoyltransferase 1A (CPT1A). Whiskers represent SEM. abcd Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise comparison. NE: normal energy, LE: low energy, LPL: Lysophospholipid supplementation.
Animals 14 03066 g001aAnimals 14 03066 g001b
Figure 2. The interaction of energy and LPL supplement the expression of the genes in the intestine tissue. (A) Fatty Acid Binding Protein 1 (FABP1). (B) Nuclear Factor Kappa B (NF-κB). Whiskers represent SEM. ab Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise comparison. NE: normal energy, LE: low energy, LPL: Lysophospholipid supplementation.
Figure 2. The interaction of energy and LPL supplement the expression of the genes in the intestine tissue. (A) Fatty Acid Binding Protein 1 (FABP1). (B) Nuclear Factor Kappa B (NF-κB). Whiskers represent SEM. ab Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise comparison. NE: normal energy, LE: low energy, LPL: Lysophospholipid supplementation.
Animals 14 03066 g002
Figure 3. The interaction of energy and LPL supplement on the expression of the Fatty Acid Binding Protein 4 (FABP4) gene in the pancreas tissue. Whiskers represent SEM. ab Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise comparison. NE: normal energy, LE: low energy, LPL: Lysophospholipid supplementation.
Figure 3. The interaction of energy and LPL supplement on the expression of the Fatty Acid Binding Protein 4 (FABP4) gene in the pancreas tissue. Whiskers represent SEM. ab Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise comparison. NE: normal energy, LE: low energy, LPL: Lysophospholipid supplementation.
Animals 14 03066 g003
Table 1. Ingredient composition and calculated nutrient content of the basal diets (as fed basis).
Table 1. Ingredient composition and calculated nutrient content of the basal diets (as fed basis).
Breeder DietsOffspring Diet
Ingredients (g/kg)Normal DietLow Energy DietBroiler Starter (1 to 7 d)
Corn664.00673.00553.90
Soybean meal177.00176.00384.00
Corn gluten meal0.000.0010.00
Wheat bran38.0038.000.00
Soybean oil13.005.0010.10
Limestone82.0082.0011.30
Dicalcium phosphate13.0013.0013.40
Sodium bicarbonate2.502.502.20
NaCl2.202.202.50
L-Lysine hydrochloride--2.20
DL-Methionine1.601.603.40
L-Threonine0.700.701.10
Choline chloride, 60%1.001.000.80
Phytase 10.000.000.05
Multienzyme 20.000.000.10
Broiler vitamin-mineral premix 30.000.005.00
Breeder vitamin-mineral premix 45.005.000.00
Lysophospholipid0.000.000.00
Total100010001000
Calculated nutrients (%)
Metabolizable Energy (kcal/kg)280027603030
Crude protein13.0013.0024.13
Digestible lysine0.560.561.28
Digestible methionine + cysteine0.540.540.95
Digestible threonine0.470.470.86
Digestible isoleucine0.430.430.87
Digestible valine0.470.470.96
Ca3.43.40.96
Available P0.350.350.48
Na0.180.180.16
Choline (mg/kg)120012001455
1 Phytase: Ronozyme® HiPhos 20,000 FYT/g (one FYT is defined as the amount of enzyme that releases 1 μmol of inorganic phosphate from phytate substrate per minute under reaction conditions with a phytate concentration of 5.0 mM/L at pH 5.5 and temperature 37 °C). 2 Multienzyme matrix value per kg: 500,000 kcal/kg metabolizable energy, 2000% protein, 80% lysine, 80% methionine + cysteine, and 80% threonine. 3 Vitamin and mineral supplied per kg diet: 12,000 IU Vitamin A, 5000 IU Vitamin D3, 80 IU Vitamin E, 3.2 mg vitamin K3, 3.2 mg vitamin B1, 65 mg niacin, 20 mg pantothenic acid, 3.4 mg vitamin B6, 0.22 mg biotin, 2.20 mg folic acid, 0.017 mg vitamin B12, 120 mg manganese, 110 mg zinc, 20 mg iron, 16 mg copper, 1.25 mg iodine, and 0.3 mg selenium. 4 Vitamin and mineral supplied per kg diet: 11,000 IU Vitamin A, 3500 IU Vitamin D3, 100 IU Vitamin E, 3.0 mg vitamin K3, 3.0 mg vitamin B1, 35 mg niacin, 15 mg pantothenic acid, 3.0 mg vitamin B6, 0.15 mg biotin, 1.50 mg folic acid, 0.02 mg vitamin B12, 120 mg manganese, 110 mg zinc, 40 mg iron, 16 mg copper, 1.25 mg iodine, and 0.3 mg selenium.
Table 2. Primers for Real Time-PCR assays.
Table 2. Primers for Real Time-PCR assays.
Gene NameForward Primers (5′–3′)Reverse Primers (5′–3′)GenBank
Accession No.
Product LengthMelting Temperature (Tm)Reference
PPARγCATCAGGTTTGGGCGAATGCTAACTGGTCGATGTCGCTGGNM_001001460.27660[29]
PGC-1αCATGTGCAACCAGGACTCTGTGTCTGCATCCAGGTCGTTCNM_001006457.213159[29]
RBPTGGGAACGGGATGAAAGTGGAGAGGAGGTGCTTGATTGCCNM_205463.218460Present study
CPT1ATGAGCACTCTTGGGCAGATGTCTCCTTTGCAGTGTCCGTCNM_001012898.110860Present study
LPCAT3CCTCATCGTGTCCATCCTGTGTACGACCCATAAGCCTCAGXM_040661607.120259Present study
TGF-βCTCGACACCGACTACTGCTTTTCCACTGCAGATCCTTGCGNM_001318456.19560Present study
FABP1ACTGGCTCCAAAGAATGACCAATGTGTCTCCGTTGAGTTCGGTCACNM_204192.416261Not published
NF-κBTACTGATTGCTGCTGGAGTTGATGTCTTGTGCCATCGTATGTAGTGCTGTCNM_205134.215663[31]
FABP4CTGGCCTGACAAAATGTGCGCTTCCTGGTAGCAAACCCCANM_204290.210960[30]
ASCLGCCAACAAGAAGATGAGCAAAGGAGTTCATGTCGTGGGAGTNM_204412.216259Present study
LPLACTTTTTCGCCGCTGCACCCCAGCTTTCATACATTCCTGTCNM_205282.229760Present study
GAPDHGAAGCTTACTGGAATGGCTTTCCCGGCAGGTCAGGTCAACAANM_204305.26660[29]
Table 3. Growth performance of offspring (from 0 to 7 days of age) that hatched from breeders fed with dietary treatments for 8 and 12 weeks (57 and 61-week-old, respectively).
Table 3. Growth performance of offspring (from 0 to 7 days of age) that hatched from breeders fed with dietary treatments for 8 and 12 weeks (57 and 61-week-old, respectively).
57-Week-Old Breeders61-Week-Old Breeders
Main Effects ABW 1 (g)ADG 2 (g)ADFI 3 (g)FCR 4ABW (g)ADG (g)ADFI (g)FCR
Energy (kcal/kg)
2800 195.64 a21.9021.720.98205.7723.2422.440.95
2760 190.73 b21.3621.290.99205.6223.2722.140.94
LPL (g/kg)
0 186.16 b20.62 b21.351.02 b199.57 b22.57 b21.970.96 b
0.5 200.21 a22.65 a21.660.95 a211.81 a24.13 a22.610.93 a
Interactions
Energy (kcal/kg)LPL 5
(g/kg)
28000188.6620.8321.431.02198.9722.5622.020.97
0.5202.6222.9722.010.95212.5724.2922.870.93
27600183.6520.4021.261.03200.1822.5821.930.96
0.5197.8122.3221.320.95211.0523.9722.350.92
SEM 1.770.240.250.0091.070.180.270.92
p-Value
Energy 0.020.070.160.600.900.500.360.29
LPL 0.00010.00010.300.00010.00010.00010.060.002
Energy × LPL 0.960.720.400.600.290.460.510.75
ab Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise test. 1 Average body weight. 2 Average daily gain. 3 Average daily feed intake. 4 Feed conversion ratio. 5 Lysophospholipid.
Table 4. Blood biochemical parameters of day-old offspring of the second hatch, which hatched from breeders fed for 12 weeks (61-week-old) with dietary treatments.
Table 4. Blood biochemical parameters of day-old offspring of the second hatch, which hatched from breeders fed for 12 weeks (61-week-old) with dietary treatments.
Main Effects TG (mg/dL) 1Cholesterol (mg/dL)ALT 2 (U/L)AST 3 (U/L)ALP 4
(U/L)
Albumin
(g/dL)
Energy (kcal/kg)
2800 91.14549.82 a34.35216.50 b3142.850.88
2760 96.28504.62 b39.00269.59 a3046.000.84
LPL (g/kg)
0 106.28 a527.1338.21251.19 a3055.000.86
0.5 81.14 b527.3635.14235.00 b3133.850.86
Interactions
Energy (kcal/kg)LPL 5
(g/kg)
28000106.57553.7037.85221.442782.85 c0.91
0.575.71546.0430.85211.703502.85 a0.85
27600106.00500.5038.57280.843327.14 b0.81
0.586.57508.7239.42258.232764.85 c0.87
SEM 4.5415.652.974.57247.760.04
p-Value
Energy 0.340.020.190.00010.740.46
LPL 0.00010.990.380.0060.781.00
Energy × LPL 0.290.670.270.240.030.32
abc Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise test. 1 Triglyceride. 2 Alanine aminotransferase. 3 Aspartate aminotransferase. 4 Alkaline phosphatase. 5 Lysophospholipid.
Table 5. The hepatic antioxidative capability of day-old offspring of the second hatch, which hatched from breeders fed for 12 weeks (61-week-old) with dietary treatments.
Table 5. The hepatic antioxidative capability of day-old offspring of the second hatch, which hatched from breeders fed for 12 weeks (61-week-old) with dietary treatments.
Main Effects SOD 1
(U/mg)
GPx 2
(U/mg)
TP 3
(U/mg)
TAC 4
(U/mg)
MDA 5 (mmol/mg)
Energy (kcal/kg)
2800 240.3966.9215.352.48146.50
2760 232.9266.5017.072.61138.57
LPL (g/kg)
0 259.00 a64.57 b15.502.58142.14
0.5 214.32 b68.85 a16.922.51142.92
Interactions
Energy (kcal/kg)LPL 6
(g/kg)
28000223.57 c63.4214.572.43134.28 c
0.5257.21 b70.4216.142.54158.71 a
27600294.42 a65.7116.422.73150.00 b
0.5171.42 d67.2817.712.49127.14 d
SEM 11.961.571.000.188.48
p-Value
Energy 0.590.810.160.560.43
LPL 0.0040.020.230.770.93
Energy × LPL 0.00010.150.900.420.02
abcd Values within a column followed by different superscripts are significantly different. p < 0.05; Tukey’s pairwise test. 1 Superoxide dismutase. 2 Glutathione peroxidase. 3 Total protein. 4 Total antioxidative capacity. 5 Malondialdehyde. 6 Lysophospholipid.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sedghi, M.; Javanmard, F.; Amoozmehr, A.; Zamany, S.; Mohammadi, I.; Kim, W.; Choppa, V.S.R. Lysophospholipid Supplementation in Broiler Breeders’ Diet Benefits Offspring’s Productive Performance, Blood Parameters, and Hepatic β-Oxidation Genes. Animals 2024, 14, 3066. https://doi.org/10.3390/ani14213066

AMA Style

Sedghi M, Javanmard F, Amoozmehr A, Zamany S, Mohammadi I, Kim W, Choppa VSR. Lysophospholipid Supplementation in Broiler Breeders’ Diet Benefits Offspring’s Productive Performance, Blood Parameters, and Hepatic β-Oxidation Genes. Animals. 2024; 14(21):3066. https://doi.org/10.3390/ani14213066

Chicago/Turabian Style

Sedghi, Mohammad, Fatemeh Javanmard, Anvar Amoozmehr, Saeid Zamany, Ishmael Mohammadi, Woo Kim, and Venkata Sesha Reddy Choppa. 2024. "Lysophospholipid Supplementation in Broiler Breeders’ Diet Benefits Offspring’s Productive Performance, Blood Parameters, and Hepatic β-Oxidation Genes" Animals 14, no. 21: 3066. https://doi.org/10.3390/ani14213066

APA Style

Sedghi, M., Javanmard, F., Amoozmehr, A., Zamany, S., Mohammadi, I., Kim, W., & Choppa, V. S. R. (2024). Lysophospholipid Supplementation in Broiler Breeders’ Diet Benefits Offspring’s Productive Performance, Blood Parameters, and Hepatic β-Oxidation Genes. Animals, 14(21), 3066. https://doi.org/10.3390/ani14213066

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop